BiotechTube
Home/Oryx Translational Medicine/Dr. Ottheinz Krebs
DO

Dr. Ottheinz Krebs

Chief Operating Officer

Oryx Translational Medicine

Therapeutic Areas

Oncology

Oryx Translational Medicine Pipeline

DrugIndicationPhase
ParvOryxRecurrent Glioblastoma / Solid CancersPhase 1/2
VicOryxSolid CancersPhase 1/2
MicOryxSolid CancersPhase 1/2

Leadership Team at Oryx Translational Medicine

DB
Dr. Bernard Huber
Chief Executive Officer
DD
Dr. Dr. Michael Dahm
Chief Medical Officer
View full Oryx Translational Medicine profile